we offer comprehensive support for Post-Marketing Observational Studies (PMOS), ensuring real-world insights into the safety, effectiveness, and usage patterns of pharmaceutical products after they reach the market. 

Our experienced team collaborates with sponsors to design and manage PMOS in full compliance with local regulatory requirements and Good Pharmacoepidemiology Practices (GPP). These non-interventional studies are vital for continuous product evaluation and risk management, helping our clients strengthen their product’s safety profile and market position. 

Our PMOS Capabilities Include:

• Study protocol and CRF development
• Site selection, initiation, and management
• Patient recruitment and engagement strategies
• Data collection and management (In-house Developed EDC)
• Screening and Randomization (In-house Developed IWRS)
• safety reporting
• Regulatory submission support
• Statistical analysis and final report generation

With a focus on quality, transparency, and regulatory compliance, Innovate Research ensures that every PMOS delivers meaningful, actionable results to guide better healthcare decisions and works with specialized centers across Global in broad coverage of therapeutic areas.